URGN · UroGen Pharma Ltd. · Documents
$35.48
+0.47 (+1.34%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$1.77B
Shares
48.88M
Volume · Oct 21
776.99K
Avg daily vol (3M)
885.7K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-03-14 | — | |
| 10-K | — | 2024-03-14 | 2023-12-31 | |
| 8-K | — | 2024-03-04 | — | |
| 8-K | — | 2024-03-01 | — | |
| 8-K | — | 2024-02-07 | — | |
| 8-K | — | 2024-01-17 | 2024-01-16 | |
| 8-K | — | 2024-01-02 | 2023-12-28 | |
| 8-K | — | 2023-11-14 | — | |
| 10-Q | — | 2023-11-14 | 2023-09-30 | |
| 8-K | — | 2023-09-11 | 2023-09-07 | |
| S-3 | — | 2023-09-08 | — | |
| 10-Q | — | 2023-08-10 | 2023-06-30 | |
| 8-K | — | 2023-08-10 | — | |
| ARS | — | 2023-08-01 | 2022-12-31 | |
| DEFA14A | — | 2023-08-01 | — | |
| DEF 14A | — | 2023-08-01 | 2023-09-07 | |
| 8-K | — | 2023-07-27 | 2023-07-26 | |
| 8-K | — | 2023-07-25 | — | |
| 8-K | — | 2023-05-11 | — | |
| 10-Q | — | 2023-05-11 | 2023-03-31 | |
| 10-K/A | — | 2023-05-01 | 2022-12-31 | |
| 10-K | — | 2023-03-24 | 2022-12-31 | |
| 8-K | — | 2023-03-22 | 2023-03-16 | |
| S-3/A | — | 2022-11-16 | — | |
| S-3 | — | 2022-11-15 | — | |
| 8-K | — | 2022-11-10 | — | |
| 10-Q | — | 2022-11-10 | 2022-09-30 | |
| 8-K | — | 2022-11-09 | 2022-11-08 | |
| 8-K | — | 2022-10-21 | — | |
| 8-K | — | 2022-09-12 | 2022-09-08 | |
| 8-K | — | 2022-08-11 | — | |
| 10-Q | — | 2022-08-11 | 2022-06-30 | |
| 8-K | — | 2022-06-13 | 2022-06-08 | |
| DEFA14A | — | 2022-05-17 | — | |
| 10-Q | — | 2022-05-10 | 2022-03-31 | |
| 8-K | — | 2022-05-10 | — | |
| DEF 14A | — | 2022-05-02 | 2022-06-08 | |
| DEFA14A | — | 2022-05-02 | — | |
| 10-K | — | 2022-03-21 | 2021-12-31 | |
| 8-K | — | 2022-03-21 | 2022-03-17 | |
| 8-K | — | 2022-03-08 | 2022-03-07 | |
| 8-K | — | 2021-11-15 | 2021-11-11 | |
| 10-Q | — | 2021-11-15 | 2021-09-30 | |
| 8-K | — | 2021-11-10 | — | |
| 8-K | — | 2021-09-13 | — | |
| 8-K | — | 2021-08-04 | — | |
| 10-Q | — | 2021-08-04 | 2021-06-30 | |
| 8-K | — | 2021-07-14 | — | |
| 8-K | — | 2021-06-08 | 2021-06-07 | |
| 10-Q | — | 2021-05-13 | 2021-03-31 |
Showing 51–100 of 124 filings
Key facts
CIK
1668243
CUSIP
M96088105
13F (30d)
16 filings
16 filers
Visit website
Investor relations